Annual EBITDA
-$31.06 M
-$7.26 M-30.48%
December 31, 2023
Summary
- As of February 7, 2025, GNPX annual EBITDA is -$31.06 million, with the most recent change of -$7.26 million (-30.48%) on December 31, 2023.
- During the last 3 years, GNPX annual EBITDA has fallen by -$13.12 million (-73.15%).
- GNPX annual EBITDA is now -2809.11% below its all-time high of -$1.07 million, reached on December 31, 2015.
Performance
GNPX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$4.32 M
+$2.19 M+33.67%
September 30, 2024
Summary
- As of February 7, 2025, GNPX quarterly EBITDA is -$4.32 million, with the most recent change of +$2.19 million (+33.67%) on September 30, 2024.
- Over the past year, GNPX quarterly EBITDA has increased by +$3.46 million (+44.46%).
- GNPX quarterly EBITDA is now -1236.90% below its all-time high of -$323.30 thousand, reached on March 31, 2016.
Performance
GNPX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$22.82 M
+$3.46 M+13.17%
September 30, 2024
Summary
- As of February 7, 2025, GNPX TTM EBITDA is -$22.82 million, with the most recent change of +$3.46 million (+13.17%) on September 30, 2024.
- Over the past year, GNPX TTM EBITDA has increased by +$8.83 million (+27.91%).
- GNPX TTM EBITDA is now -6957.07% below its all-time high of -$323.30 thousand, reached on March 31, 2016.
Performance
GNPX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GNPX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.5% | +44.5% | +27.9% |
| 3 y3 years | -73.2% | +53.3% | +17.8% |
| 5 y5 years | -151.9% | +53.3% | +17.8% |
GNPX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -50.4% | at low | at high | +53.3% | -17.2% | +27.9% |
| 5 y | 5-year | -191.1% | at low | -78.3% | +53.3% | -113.8% | +27.9% |
| alltime | all time | -2809.1% | at low | -1236.9% | +53.3% | -6957.1% | +27.9% |
Genprex EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.32 M(-33.7%) | -$22.82 M(-13.2%) |
| Jun 2024 | - | -$6.52 M(+8.7%) | -$26.28 M(-5.5%) |
| Mar 2024 | - | -$5.99 M(+0.2%) | -$27.79 M(-10.5%) |
| Dec 2023 | -$31.06 M(+30.5%) | -$5.98 M(-23.1%) | -$31.06 M(-1.9%) |
| Sep 2023 | - | -$7.78 M(-3.1%) | -$31.65 M(+5.4%) |
| Jun 2023 | - | -$8.03 M(-13.2%) | -$30.03 M(+8.2%) |
| Mar 2023 | - | -$9.26 M(+40.9%) | -$27.76 M(+16.6%) |
| Dec 2022 | -$23.81 M(+15.3%) | -$6.57 M(+6.6%) | -$23.81 M(-0.7%) |
| Sep 2022 | - | -$6.16 M(+6.9%) | -$23.98 M(+12.9%) |
| Jun 2022 | - | -$5.76 M(+8.7%) | -$21.25 M(+9.1%) |
| Mar 2022 | - | -$5.30 M(-21.4%) | -$19.47 M(-5.7%) |
| Dec 2021 | -$20.65 M(+15.1%) | -$6.75 M(+96.5%) | -$20.65 M(+8.0%) |
| Sep 2021 | - | -$3.43 M(-13.9%) | -$19.13 M(+3.6%) |
| Jun 2021 | - | -$3.98 M(-38.6%) | -$18.47 M(-2.1%) |
| Mar 2021 | - | -$6.49 M(+24.2%) | -$18.85 M(+5.1%) |
| Dec 2020 | -$17.94 M | -$5.22 M(+88.5%) | -$17.94 M(+18.5%) |
| Sep 2020 | - | -$2.77 M(-36.6%) | -$15.14 M(+2.7%) |
| Jun 2020 | - | -$4.37 M(-21.5%) | -$14.74 M(+4.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$5.57 M(+129.9%) | -$14.07 M(+31.9%) |
| Dec 2019 | -$10.67 M(-13.5%) | -$2.42 M(+2.0%) | -$10.67 M(-8.6%) |
| Sep 2019 | - | -$2.38 M(-35.8%) | -$11.67 M(+1.7%) |
| Jun 2019 | - | -$3.70 M(+70.7%) | -$11.48 M(-16.9%) |
| Mar 2019 | - | -$2.17 M(-36.8%) | -$13.81 M(+12.0%) |
| Dec 2018 | -$12.33 M(+272.6%) | -$3.43 M(+57.0%) | -$12.33 M(+28.9%) |
| Sep 2018 | - | -$2.18 M(-63.8%) | -$9.56 M(+18.2%) |
| Jun 2018 | - | -$6.03 M(+779.3%) | -$8.09 M(+149.5%) |
| Mar 2018 | - | -$685.70 K(+3.3%) | -$3.24 M(-2.0%) |
| Dec 2017 | -$3.31 M(-19.9%) | -$663.70 K(-7.1%) | -$3.31 M(-9.2%) |
| Sep 2017 | - | -$714.30 K(-39.5%) | -$3.64 M(-0.1%) |
| Jun 2017 | - | -$1.18 M(+57.2%) | -$3.65 M(-19.9%) |
| Mar 2017 | - | -$750.70 K(-24.8%) | -$4.56 M(+10.3%) |
| Dec 2016 | -$4.13 M(+286.9%) | -$998.90 K(+38.8%) | -$4.13 M(+31.9%) |
| Sep 2016 | - | -$719.60 K(-65.6%) | -$3.13 M(+29.8%) |
| Jun 2016 | - | -$2.09 M(+546.3%) | -$2.41 M(+646.3%) |
| Mar 2016 | - | -$323.30 K | -$323.30 K |
| Dec 2015 | -$1.07 M | - | - |
FAQ
- What is Genprex annual EBITDA?
- What is the all time high annual EBITDA for Genprex?
- What is Genprex annual EBITDA year-on-year change?
- What is Genprex quarterly EBITDA?
- What is the all time high quarterly EBITDA for Genprex?
- What is Genprex quarterly EBITDA year-on-year change?
- What is Genprex TTM EBITDA?
- What is the all time high TTM EBITDA for Genprex?
- What is Genprex TTM EBITDA year-on-year change?
What is Genprex annual EBITDA?
The current annual EBITDA of GNPX is -$31.06 M
What is the all time high annual EBITDA for Genprex?
Genprex all-time high annual EBITDA is -$1.07 M
What is Genprex annual EBITDA year-on-year change?
Over the past year, GNPX annual EBITDA has changed by -$7.26 M (-30.48%)
What is Genprex quarterly EBITDA?
The current quarterly EBITDA of GNPX is -$4.32 M
What is the all time high quarterly EBITDA for Genprex?
Genprex all-time high quarterly EBITDA is -$323.30 K
What is Genprex quarterly EBITDA year-on-year change?
Over the past year, GNPX quarterly EBITDA has changed by +$3.46 M (+44.46%)
What is Genprex TTM EBITDA?
The current TTM EBITDA of GNPX is -$22.82 M
What is the all time high TTM EBITDA for Genprex?
Genprex all-time high TTM EBITDA is -$323.30 K
What is Genprex TTM EBITDA year-on-year change?
Over the past year, GNPX TTM EBITDA has changed by +$8.83 M (+27.91%)